Ukrainian Pharma Companies Reportedly Leaving Country Amid Specialist Shortage
Auf einen Blick
- Ukrainian pharmaceutical companies are reportedly exiting the country due to a severe shortage of specialists and labor.
- Biopharma plans to open an €85 million production facility in Romania by late 2027.
KI-generierte Zusammenfassung
MOSCOW, June 23. /TASS/. Ukrainian pharmaceutical companies are leaving the country due to a shortage of specialists, a source in the Russian law enforcement agencies told TASS.
"The remnants of Ukrainian pharmaceuticals are leaving Ukraine. The decision of the Ukrainian 'businessmen' is primarily due to the catastrophic shortage of not only specialists in Ukraine, but also of ordinary labor," the source said.
According to the source, the Ukrainian biotechnology company Biopharma intends to launch an 85 million euro production facility in Arad, Romania by the end of 2027. Construction has already been completed, and all engineering networks are to be connected by September 1.




